Recent DTIL News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/15/2025 12:10:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2025 12:09:42 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 12:08:32 PM
- Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B • Business Wire • 04/15/2025 11:01:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/04/2025 11:38:08 AM
- Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference • Business Wire • 04/01/2025 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 11:02:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 11:00:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2025 11:00:04 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/26/2025 10:09:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/26/2025 09:03:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2025 11:30:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2025 11:30:08 AM
- Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update • Business Wire • 03/26/2025 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/24/2025 07:13:05 PM
- Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025 • Business Wire • 03/21/2025 11:01:00 AM
- Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025 • Business Wire • 03/20/2025 11:01:00 AM
- Precision BioSciences Presents Preclinical Efficacy and Durability Data on PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy (DMD) at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference • Business Wire • 03/19/2025 11:01:00 AM
- Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B • Business Wire • 03/17/2025 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2025 09:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:10 AM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM